Parkinson David Ross
- SEC CIK
- 0001451935
No open-market purchases or sales filed in the past year.
Current role at each company
- EPIX ESSA Pharma Inc.President and CEOas of Oct 15, 2025
- CTIC Cti Biopharma CorpDirectoras of Jun 26, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Parkinson David Ross as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
EPIX ESSA Pharma Inc.
President and CEO3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 18, 2023 (view filing) | Dec 14 | 4 days | Parkinson David RossChief Executive Officer | PPurchase | +9.22K | $2.30 | +$21.2K | +16.3%65.7K after | |
| Jan 5, 2023 (view filing) | Dec 22-30, 2022 | 14 daysLate | Parkinson David RossChief Executive Officer | PPurchase | +24.4K | $2.42 | +$59.0K | +76.1%56.5K after | 2 lots |
| Jul 5, 2022 (view filing) | Jun 30 | 5 days | Parkinson David RossChief Executive Officer | PPurchase | +4.89K | $2.96 | +$14.5K | +18.0%32.1K after |